Stay updated on Oral Voxelotor in Sickle Cell Disease Clinical Trial
Sign up to get notified when there's something new on the Oral Voxelotor in Sickle Cell Disease Clinical Trial page.
Latest updates to the Oral Voxelotor in Sickle Cell Disease Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; a minor page version update with no impact on study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check21 days agoChange DetectedPublications section wording updated to indicate that PubMed data are automatically filled from PubMed, and the page revision label changed from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check29 days agoChange DetectedRemoved the government funding notice banner that previously warned of potential information delays and limited responses. The page now presents the study details without that operating-status notice.SummaryDifference0.3%
- Check43 days agoChange DetectedNo significant updates to the study details, eligibility criteria, outcomes, or locations are visible; the page appears unchanged.SummaryDifference0.3%
- Check72 days agoChange DetectedUpdated page to version v3.2.0 and added a government-operating-status notice; removed the Hb SS disease resource reference from v3.1.0.SummaryDifference4%
- Check79 days agoChange DetectedUpdate to v3.1.0 with a new mention of Hb SS disease, and removal of several general drug-safety and pharmaceutical terms, indicating a shift toward a more focused medical topic rather than broad safety content.SummaryDifference0.7%
Stay in the know with updates to Oral Voxelotor in Sickle Cell Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Voxelotor in Sickle Cell Disease Clinical Trial page.